World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
145
Citations
93660
World Ranking
1370
National Ranking
796

Research.com Recognitions

  • 2002 - Member of the National Academy of Medicine (NAM)

Overview

Stanley Fahn is affiliated with Columbia University in the United States and has contributed extensively to the fields of medicine and neuroscience. Their primary area of research spans neurology and cellular and molecular neuroscience, with significant focus also on genetics, psychiatry and mental health, and physiology.

The scientist's research broadly addresses neurological disorders and treatments, with a marked emphasis on Parkinson's disease mechanisms and treatments. Other notable research topics include attention deficit hyperactivity disorder, genetic neurodegenerative diseases, lysosomal storage disorders research, genetics and neurodevelopmental disorders, and nuclear receptors and signaling.

Frequent publication venues for Stanley Fahn include:

  • Movement Disorders Clinical Practice
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Movement Disorders
  • Parkinsonism & Related Disorders
  • npj Parkinson s Disease

The scientist has collaborated regularly with several researchers, including:

  • Mark Hallett (55 coauthored works)
  • Pablo Mir (32 coauthored works)
  • Daniela Berg (32 coauthored works)
  • Marcelo Merello (32 coauthored works)
  • Anthony E. Lang (32 coauthored works)

Notable recent papers published by Stanley Fahn include:

  • "COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside," 2020, npj Parkinson s Disease
  • "Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease," 2021, npj Parkinson s Disease
  • "Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations," 2020, Brain
  • "Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's Disease," 2020, Movement Disorders
  • "Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort," 2023, Movement Disorders

Stanley Fahn's academic influence is further recognized by their membership in the National Academy of Medicine since 2002. Their body of work reflects an interdisciplinary approach combining clinical neurology, molecular genetics, and neurodegenerative disease mechanisms, with an emphasis on understanding Parkinson's disease and related movement disorders.

Best Publications

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

    M. Hutton;C. L. Lendon;P. Rizzu;M. Baker

  • Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

    Curt R. Freed;Paul E. Greene;Robert E. Breeze;Wei-Yann Tsai

  • Levodopa and the progression of Parkinson's disease.

    Fahn S;Oakes D;Shoulson I;Kieburtz K

  • Phenomenology and classification of dystonia: a consensus update.

    Alberto Albanese;Kailash Bhatia;Susan B. Bressman;Mahlon R. DeLong

  • Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

    Ellen Sidransky;Michael A. Nalls;Jan O. Aasly;Judith Aharon-Peretz

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

    Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe

  • Description of Parkinson's disease as a clinical syndrome.

    Stanley Fahn

  • Validity and reliability of a rating scale for the primary torsion dystonias

    R. E. Burke;S. Fahn;C. D. Marsden;S. B. Bressman

  • Core assessment program for intracerebral transplantations (CAPIT).

    J. William Langston;Hakan Widner;Christopher G. Goetz;David Brooks

  • The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein

    Laurie J. Ozelius;Jeffrey W. Hewett;Curtis E. Page;Susan B. Bressman

  • Huntington disease: Clinical care and evaluation

    Ira Shoulson;Stanley Fahn

  • Tolcapone COMT inhibition for the treatment of Parkinson's disease

    Stanley Fahn

  • Classification of dystonia

    S Fahn;S B Bressman;C D Marsden

  • Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    J.A. Obeso;M. Stamelou;M. Stamelou;C.G. Goetz;W. Poewe

  • Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole.

    S. Frucht;J.D. Rogers;P.E. Greene;M.F. Gordon

  • Concept and classification of dystonia.

    Fahn S

  • A controlled trial of rasagiline in early Parkinson disease: The tempo study

    Andrew Siderowf;Matthew Stern;Ira Shoulson;Karl Kieburtz

  • DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

    C. F. Lippa;J. E. Duda;M. Grossman;H. I. Hurtig

  • Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

    Robert G Holloway;Ira Shoulson;Stanley Fahn;Karl Kieburtz

Frequent Co-Authors

Elan D. Louis
Elan D. Louis The University of Texas Southwestern Medical Center
Mitchell F. Brin
Mitchell F. Brin Allergan (Ireland)
Steven J. Frucht
Steven J. Frucht New York University
Karen Marder
Karen Marder Columbia University
Robert E. Burke
Robert E. Burke Columbia University
Anthony E. Lang
Anthony E. Lang University of Toronto
Howard Andrews
Howard Andrews Columbia University
Ruth Ottman
Ruth Ottman Columbia University
Joseph Jankovic
Joseph Jankovic Baylor College of Medicine
David Eidelberg
David Eidelberg Feinstein Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens many alternative and complementary pathways beyond the traditional MD. For registered nurses, accelerated options like the adn to np bridge program allow working RNs to advance swiftly to nurse practitioner status. These pathways provide flexibility and are designed for busy professionals seeking upward mobility.

Healthcare management is another vital field, with online master’s options becoming increasingly accessible. Programs listed in the cahme accredited online mha programs list offer rigorous training in administration, opening doors to leadership roles in hospitals and health systems.

For those interested in public health and preventative care, earning the best online nutrition degree can be a perfect fit. This degree prepares graduates to become nutritionists or dietitians, shaping healthier communities.

Lastly, nurses looking to advance academically without hands-on practicums can benefit from online rn to bsn programs without clinical requirements. These flexible courses help broaden career prospects while balancing work and study.

Best Scientists Citing Stanley Fahn

Trending Scientists

Recently Published Articles